Saiying Capital

Saiying Capital is a direct investment firm based in Beijing, China. Established in 2016, the firm was established by Saisheng Pharmaceutical (SZ: 300485) in cooperation with E-town International Investment and E-town Biomedical Park. The core of its investment strategy is made up of M&A and direct investment. The firm seeks to make investments in the healthcare sector. The assets are managed by the executive management team.